BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30201102)

  • 21. The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.
    Li X; Westman E; Thordardottir S; Ståhlbom AK; Almkvist O; Blennow K; Wahlund LO; Graff C
    J Alzheimers Dis; 2017; 56(1):327-334. PubMed ID: 27911308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease.
    Chiesa PA; Cavedo E; Vergallo A; Lista S; Potier MC; Habert MO; Dubois B; Thiebaut de Schotten M; Hampel H; ;
    Alzheimers Dement; 2019 Jul; 15(7):940-950. PubMed ID: 31113760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden.
    Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
    Neurology; 2017 May; 88(18):1759-1767. PubMed ID: 28381517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual Correspondence of Amyloid-β and Intrinsic Connectivity in the Posterior Default Mode Network Across Stages of Alzheimer's Disease.
    Pasquini L; Benson G; Grothe MJ; Utz L; Myers NE; Yakushev I; Grimmer T; Scherr M; Sorg C;
    J Alzheimers Dis; 2017; 58(3):763-773. PubMed ID: 28482640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints.
    Teipel S; Bakardjian H; Gonzalez-Escamilla G; Cavedo E; Weschke S; Dyrba M; Grothe MJ; Potier MC; Habert MO; Dubois B; Hampel H;
    Neuroimage Clin; 2018; 17():435-443. PubMed ID: 29159056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
    Mosconi L; De Santi S; Brys M; Tsui WH; Pirraglia E; Glodzik-Sobanska L; Rich KE; Switalski R; Mehta PD; Pratico D; Zinkowski R; Blennow K; de Leon MJ
    Biol Psychiatry; 2008 Mar; 63(6):609-18. PubMed ID: 17720148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.
    Grothe MJ; Villeneuve S; Dyrba M; Bartrés-Faz D; Wirth M;
    Neurology; 2017 Feb; 88(6):569-576. PubMed ID: 28062720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume.
    Caldwell JZK; Berg JL; Cummings JL; Banks SJ;
    Alzheimers Res Ther; 2017 Sep; 9(1):72. PubMed ID: 28899422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease.
    Cavedo E; Lista S; Houot M; Vergallo A; Grothe MJ; Teipel S; Zetterberg H; Blennow K; Habert MO; Potier MC; Dubois B; Hampel H; ; Alzheimer Precision Medicine Initiative
    Neurology; 2020 Jan; 94(1):e30-e41. PubMed ID: 31801830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.
    Jack CR; Wiste HJ; Weigand SD; Therneau TM; Knopman DS; Lowe V; Vemuri P; Mielke MM; Roberts RO; Machulda MM; Senjem ML; Gunter JL; Rocca WA; Petersen RC
    Lancet Neurol; 2017 Jun; 16(6):435-444. PubMed ID: 28456479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer's disease.
    Quevenco FC; Preti MG; van Bergen JM; Hua J; Wyss M; Li X; Schreiner SJ; Steininger SC; Meyer R; Meier IB; Brickman AM; Leh SE; Gietl AF; Buck A; Nitsch RM; Pruessmann KP; van Zijl PC; Hock C; Van De Ville D; Unschuld PG
    Alzheimers Res Ther; 2017 Mar; 9(1):24. PubMed ID: 28359293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
    Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
    Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
    Altmann A; Ng B; Landau SM; Jagust WJ; Greicius MD;
    Brain; 2015 Dec; 138(Pt 12):3734-46. PubMed ID: 26419799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimorbidity Is Associated with Preclinical Alzheimer's Disease Neuroimaging Biomarkers.
    Mendes A; Tezenas du Montcel S; Levy M; Bertrand A; Habert MO; Bertin H; Dubois B; Epelbaum S;
    Dement Geriatr Cogn Disord; 2018; 45(5-6):272-281. PubMed ID: 29953971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Asymmetry During Working Memory and Its Association with Markers of Alzheimer's Disease in Cognitively Normal Older Adults.
    Li J; Mountz EJ; Mizuno A; Shah AM; Weinstein A; Cohen AD; Klunk WE; Snitz BE; Aizenstein HJ; Karim HT
    J Alzheimers Dis; 2023; 95(3):1077-1089. PubMed ID: 37638440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.
    Mosconi L; Berti V; Quinn C; McHugh P; Petrongolo G; Varsavsky I; Osorio RS; Pupi A; Vallabhajosula S; Isaacson RS; de Leon MJ; Brinton RD
    Neurology; 2017 Sep; 89(13):1382-1390. PubMed ID: 28855400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.
    Rimajova M; Lenzo NP; Wu JS; Bates KA; Campbell A; Dhaliwal SS; McCarthy M; Rodrigues M; Paton A; Rowe C; Foster JK; Martins RN
    J Alzheimers Dis; 2008 Mar; 13(2):137-46. PubMed ID: 18376055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease.
    Aziz AL; Giusiano B; Joubert S; Duprat L; Didic M; Gueriot C; Koric L; Boucraut J; Felician O; Ranjeva JP; Guedj E; Ceccaldi M
    Neurobiol Aging; 2017 Jun; 54():22-30. PubMed ID: 28314160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic interaction is associated with lower metabolic connectivity and memory impairment in clinically mild Alzheimer's disease.
    Chang YT; Huang CW; Huang SH; Hsu SW; Chang WN; Lee JJ; Chang CC
    Genes Brain Behav; 2019 Jun; 18(5):e12490. PubMed ID: 29883038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.